Metformin

Metformin

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes

Leave a Comment / Populations And Settings, Primary Care / By / , , , , ,

Effectiveness and features of Metformin administration in diabetes mellitus OUR READERS RECOMMEND! . Seeing the popularity of this tool, we decided to offer it to your attention. Metformin is a vital drug for people with diabetes. The drug has a glucose-lowering effect that regulates blood sugar levels, reduces appetite and promotes active fat burning. The …

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes Read More »

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Leave a Comment / Populations And Settings, Primary Care / By / , , , , ,

Metformin is widely used as a first line treatment for type 2 diabetes and it is usually continued when treatment is intensified, such as with other oral agents or by insulin therapy. This systematic review looked at whether metformin is actually beneficial to patients who are using insulin. Clinical question: In people with type 2 …

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy Read More »

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

Leave a Comment / Populations And Settings, Primary Care / By / , , , ,

General information: what is glycemia in diabetes Type 2 diabetes is characterized by a constant deterioration of beta cell function, so treatment should be dynamic, involving a gradual increase in drug intervention as the disease progresses.Ideally, the blood glucose level should be maintained within the limits close to normal: before meals, blood glucose is 5-7 …

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes Read More »

treating type 2 diabetes with oral agents

ACP guidance for treating type 2 diabetes with oral agents

Leave a Comment / Populations And Settings, Primary Care / By / , , , , ,

The European Association for the study of diabetes (EASD) guidelines for the treatment of type 2 diabetes were published in the journal Diabetologia on October 05, 2018.I already wrote about this in June 2018, but there I used slides from the conference. Now an official document has been published and attached. I also made a …

ACP guidance for treating type 2 diabetes with oral agents Read More »

Metformin appears to be safe in diabetic patients with heart failure

Metformin appears to be safe in diabetic patients with heart failure

Leave a Comment / Populations And Settings, Secondary Care / By / , ,

Heart failure is more prevalent in diabetes than in the general population.  All too often, patients with such serious co-morbidities are excluded from clinical trials.  As a result, there remains uncertainty around the benefits of diabetes medications in these sub-groups of patients.  Often, we need to look at observational data to get the best available …

Metformin appears to be safe in diabetic patients with heart failure Read More »